Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments

J Antimicrob Chemother. 2017 Jul 1;72(7):2135-2136. doi: 10.1093/jac/dkx097.

Authors

L Khatchatourian¹, A Le Bourgeois², N Asseray¹, C Biron¹, M Lefebvre¹, D Navas³, M Grégoire⁴, B Gaborit¹, F Raffi¹, D Boutoille¹

Affiliations

¹ Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
² Clinical Haematology Department, University Hospital of Nantes, Nantes, France.
³ Clinical Pharmacology Department, University Hospital of Nantes, Nantes, France.
⁴ Pharmacy, University Hospital of Nantes, Nantes, France.

PMID: 28369418
DOI: 10.1093/jac/dkx097

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents*
Linezolid*
Oxazoles

Substances

Anti-Bacterial Agents
Oxazoles
Linezolid